Difficulty: Medium
Average Score: 92%
Practice
Which of the following is a first-line treatment for juvenile idiopathic arthritis?
Correct answer
A
Rationale
In pediatric nursing, it is crucial to understand the appropriate treatment options for conditions like juvenile idiopathic arthritis (JIA). The first-line treatment for JIA is nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen.
NSAIDs are preferred initially due to their effectiveness in managing pain and inflammation in JIA without the systemic side effects associated with other medications. They are also well-tolerated by children in general.
Biologics, corticosteroids, and disease-modifying antirheumatic drugs (DMARDs) are not typically used as first-line treatments for JIA. Biologics and DMARDs are usually reserved for cases where NSAIDs are ineffective or if there is a need for more aggressive therapy. Corticosteroids may be used for short-term management of severe symptoms but are not preferred due to their potential long-term side effects in children.
Educationally, understanding the rationale behind selecting NSAIDs as the first-line treatment for JIA not only reinforces knowledge of appropriate pharmacological interventions but also highlights the importance of considering factors such as efficacy, safety, and patient age when making treatment decisions in pediatric patients with chronic conditions.
NSAIDs are preferred initially due to their effectiveness in managing pain and inflammation in JIA without the systemic side effects associated with other medications. They are also well-tolerated by children in general.
Biologics, corticosteroids, and disease-modifying antirheumatic drugs (DMARDs) are not typically used as first-line treatments for JIA. Biologics and DMARDs are usually reserved for cases where NSAIDs are ineffective or if there is a need for more aggressive therapy. Corticosteroids may be used for short-term management of severe symptoms but are not preferred due to their potential long-term side effects in children.
Educationally, understanding the rationale behind selecting NSAIDs as the first-line treatment for JIA not only reinforces knowledge of appropriate pharmacological interventions but also highlights the importance of considering factors such as efficacy, safety, and patient age when making treatment decisions in pediatric patients with chronic conditions.